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The imprints left by persistent DNA viruses in the tissues can testify to the changes driving virus 20 
evolution as well as provide clues on the provenance of modern and ancient humans. However, the 21 
history hidden in skeletal remains is practically unknown, as only parvovirus B19 and hepatitis B 22 
virus DNA have been detected in hard tissues so far. Here, we investigated the DNA prevalences of 23 
38 viruses in femoral bone of recently deceased individuals. To this end, we used quantitative PCRs 24 
and a custom viral targeted enrichment followed by next-generation sequencing. The data was 25 
analyzed with a tailor-made bioinformatics pipeline. Our findings revealed bone to be a much richer 26 
source of persistent DNA viruses than earlier perceived, discovering ten additional ones, including 27 
several members of the herpes- and polyomavirus families, as well as human papillomavirus 31 and 28 
torque teno virus. Remarkably, many of the viruses found have oncogenic potential and/or are likely 29 
to reactivate in the elderly and immunosuppressed individuals. Thus, their persistence warrants 30 
careful evaluation of their clinical significance and impact on bone biology. Our findings open new 31 
frontiers for the study of virus evolution from ancient relics as well as provide new tools for the 32 




DNA viruses commonly establish persisting infections in humans, remaining thus, their genetic 35 
material imprinted in the tissues throughout life. These DNAs exhibit phylogeographies resembling 36 
those of humans[1], pointing to shared evolutionary and dispersal paths that can, together, add to 37 
the understanding of human population history and migrations[2–8]. In addition, the specific 38 
geographical distributions of DNA viruses, in both global[2,9] and local[10–12] scales, may provide 39 
new insights into the origins of unidentified individuals. 40 
In this regard, the most widely studied virus is JC polyomavirus (JCPyV), a highly prevalent pathogen 41 
with three main phylogenetic clusters spread across Africa, Asia, and Europe. JCPyV´s genotype-42 
specific global spread has been proposed as an indicator of the provenances of both modern[12] 43 
and ancient humans[13–15]. Although its timescale of evolution has been debated[16–18], recent 44 
work by Forni et al.,[8] based on ~1100 worldwide strains, supports co-dispersal of this virus with 45 
major human migratory routes as well as its co-divergence with human mitochondrial and nuclear 46 
markers.  47 
In addition to the spatial and temporal dimensions, viruses also display intriguing age-dependent 48 
distributions[19–21]. This is the case with genotype 2 of parvovirus B19, the traces of which went 49 
missing in Europe around 1970s. Thus, contemporary DNA findings of this virus variant in tissues 50 
are confined to elderly individuals or historic human remains[22]. 51 
Despite these encouraging data, the utility of the viral DNAs has not been fully addressed in forensic 52 
and anthropological settings. Reasons for this include the lack of a comprehensive picture of the 53 
overall distribution of viral DNAs in various organs, limiting the use of some human tissues in versatile 54 
scenarios, and most importantly, the fact that their prevalences in bones and teeth are almost entirely 55 
unknown.  56 
Of the latter, we were the first to detect parvovirus B19 DNA in bones from soldiers of World War 57 
II[23], followed by findings of this same virus[24] and of hepatitis B[25,26] virus in archaeological 58 
remains dated from the Neolithic to medieval times. These singular discoveries confirm the presence 59 
and preservation of viral DNA in hard tissues and call for the investigation of the full landscape of 60 
viral DNAs that here persist. 61 
In this study, we searched for 38 highly prevalent DNA viruses in the femoral bones of recently 62 
deceased individuals. To this end, we used in-house quantitative PCRs (qPCRs) and virus-targeted 63 
enrichment coupled with next-generation sequencing (NGS). 64 
Our findings significantly expand the present knowledge on the virome of human bone, opening new 65 
frontiers for the study of virus evolution as well new tools for the investigation of forensic and 66 
anthropological cases. 67 
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Materials and methods 68 
Study subjects 69 
The study cohort consisted of 27 deceased individuals of Finnish origin, aged 36 to 85 years (mean 70 
67.6) with a male:female ratio of 19:8. The postmortem interval ranged from 4 to 30 days (mean 8). 71 
The manners of death were disease (n=19), occupational disease (n=1), injury (n=5), and suicide 72 
(n=2). In none of the cases the medical records revealed the use of immunosuppressants or pre-73 
conditions related to infectious-diseases, except for one with a history of herpes-zoster a few weeks 74 
before death. The mode and cause of death are presented in Figure 2. The study protocol was 75 
reviewed by the Ethics Committee of Helsinki and Uusimaa Hospital District (approval 76 
164/13/03/00/2014). 77 
Specimen collection and preparation 78 
A 5-10 cm piece of the femoral diaphysis was collected and cut longitudinally with an oscillating tip 79 
saw. The bone was cleaned using a toothbrush and washed sequentially in distilled water, 0.1 % 80 
sodium hypochlorite, and 96.1 w/w ethanol. The bones were let to dry for 5 to 7 days at room 81 
temperature under flow in a laminar hood. From each individual, the external and internal surfaces 82 
of femoral bone were sampled using a dentist drill (Schick Qube) except for three cases, in which 83 
the bone was cryomilled (Spex 6775 Freezer/mill; Spex). The sample preparations and drillings were 84 
performed in enclosed dedicated facilities, using full-body protection suits. 85 
DNA extraction 86 
Approximately 0.1-0.4g of bone powder were lysed and extracted as specified before[23] and eluted 87 
in a final volume of 50-100 µl. The DNA extractions were performed in enclosed facilities, dedicated 88 
to the extraction of human DNA. No viral work is performed in these rooms. 89 
The total DNA was quantitated with Quant-iT™ PicoGreen™ dsDNA Assay Kit (Thermo Fisher 90 
Scientific). 91 
The quality of the total DNA was evaluated with the Genomic DNA Reagent Kit in a LabChip  GX 92 
Instrument (Perkin Elmer). 93 
Quantitative PCRs 94 
The quantifications of parvovirus B19, Merkel cell, JC and BK polyomaviruses, and nine human 95 
herpesviruses as well as of the human single-copy gene RNase P were performed with in-house 96 
quantitative PCRs (qPCRs) as described[27–30] [Pyöriä et al. in press]. The quantification of 97 
hepatitis B virus and human papillomavirus type 31 DNAs were performed with commercial kits 98 
(Hepatitis B Virus PCR Kit, GeneProof; Genesig Human papillomavirus 31 Standard kit, 99 
PrimerDesign) according to the manufacturer instructions. 100 
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For the quantification of torque teno virus, a qPCR was optimized[31,32] to amplify and detect the 101 
conserved untranslated region (UTR) of the virus using the following primers: AMTS fwd (5'-102 
GTGCCGNAGGTGAGTTTA-'3), AMTAS rev (5'-AGCCCGGCCAGTCC-'3), AMTASgr4 rev (5'-103 
AGCCCGGCCAGACC-'3) and AMTPTU probe (5'-FAM-TCAAGGGGCAATTCGGGCT-BHQ1-'3). 104 
The qPCR reaction consisted of 1x Maxima probe qPCR Master mix (Thermo Fisher Scientific) with 105 
0.03 µM of ROX passive reference dye, 0.5 µM of each of the primers, 0.4 µM of the probe, 5 µl of 106 
the template, and nuclease-free water to a final volume of 25 µl. After initial denaturation at +95°C 107 
for 10 min, the qPCR cycles were +95 °C for 15 s and +55 °C for 1 min for 45 cycles. 108 
The qPCR amplicons were 63 to 154 nucleotides in length.  109 
Plasmid dilution series were used in all the qPCR runs as positive controls and to create standard 110 
curves for quantification. The plasmids of parvovirus B19, human herpesvirus 1-8, Merkel cell, JC 111 
and BK polyomaviruses, and RNaseP are described elsewhere[33][Pyöriä et al. in press]. For torque 112 
teno virus, a plasmid, named 10B, containing 1184 nucleotides of the virus was cloned from a healthy 113 
blood donor’s plasma (GenBank MT448658).  114 
The virus amplifications were completed with AriaMx Real-Time PCR System except for those of 115 
torque teno virus, RNaseP, and human papillomavirus 31 that were analyzed with Stratagene 116 
Mx3005P qPCR System (both Agilent). 117 
The qPCR mixes, sample handling, plasmid dilutions, and amplifications, were performed each in 118 
completely separate rooms, following strict protocols and work-flows to prevent contamination. 119 
Negative controls (PCR-grade water) were included in every step starting from the DNA extraction. 120 
PCR inhibition tests 121 
PCR efficiency due to carryover of inhibitors following DNA extraction was controlled using DNA 122 
extracts from bone together with or in parallel to a pre-quantified RNaseP plasmid[33].  123 
To evaluate the performance of different polymerases and the quantification accuracy, four different 124 
commercial master mixes were tested. From this, Maxima probe qPCR master mix was selected 125 
and used throughout the study.  126 
The impact of residual EDTA on the qPCR performance was examined by testing varying EDTA 127 
concentrations in the lysis buffer (0.5 to 500 nM) and by adding excess EDTA (0.05 to 50 nM) to the 128 
qPCR reaction. In addition, pre-quantified plasmid dilutions were extracted following the bone 129 
extraction protocol (i.e. lysis buffer containing 500 nM EDTA). 130 
The impact of residual Ca2+-ions from bone in the extracts was investigated by addition of MgCl2 to 131 




Library preparation, viral enrichment, and sequencing 134 
The sequencing libraries were prepared on 10 to 1000 ng of total DNA using the KAPA HyperPlus 135 
library preparation kit (Roche), following the manufacturer protocol with two modifications: 1) 136 
mechanical fragmentation with a Covaris E220 of the DNA with target fragments of 200 nt and 2) the 137 
use of xGen Dual Index UMI Adapters (Integrated DNA Technologies). 138 
After sonication, the fragment length distributions were analyzed with the DNA High Sensitivity 139 
Reagent Kit in a LabChip GX Instrument (Perkin Elmer). 140 
The viral enrichment was performed using two consecutive rounds of hybridization on individual 141 
samples following recommendations for low input DNA (MyBaits v4 kit; Arbor Biosciences). For each 142 
library, 200 ng per round of biotinylated RNA-baits were used. The baits were 100 nt in length and 143 
designed with 2X tiling (Supplementary Table 1 for a list of viruses).  xGen Universal Blockers-TS 144 
Mix (Integrated DNA Technologies) were used to block unspecific binding to the adapters during 145 
hybridization. 146 
During library preparation and viral enrichment, the libraries were amplified 3x13-25 cycles. The 147 
clean-up steps were performed with either KAPA Pure Beads (Roche) or MinElute PCR Purification 148 
Kit (Qiagen). 149 
The enriched libraries were quantified with KAPA Library Quantification Kit (Roche) using Stratagene 150 
3005P qPCR System (Agilent) and subsequently pooled for sequencing on NovaSeq 6000 (SP 151 
PE151 reagent kit; Illumina). 152 
NGS data analysis  153 
The viral genomic sequences were reconstructed after removal of PCR duplicates, using a 154 
customized bioinformatics pipeline (TRACESPipe; [Pratas et al. in revision; available for download 155 
at https://github.com/viromelab/tracespipe). 156 
The consensus, as well as single sequences (when in low coverage), were confirmed by BLAST 157 
(NCBI). The highest similarity was used to classify the virus genotype. For parvovirus B19, the 158 
sequences covering >70 % of the viral genome (n=7) were aligned with previously published full or 159 
near-full length sequences in EMBL-EBI Clustal Omega and analyzed with Bioedit v.7.2.5 (Ibis 160 
Biosciences). 161 
For the following viruses, the consensus sequences will be available in GenBank with respective 162 
accession numbers: parvovirus B19 (7 sequences; MT410184-MT410190); human papillomavirus 163 




Statistical analysis 166 
The differences in viral or cell copy numbers in the external and internal surfaces of femoral bone 167 
were calculated with Student’s t-test in RStudio (version 1.0.153). 168 
Results 169 
Viral DNA prevalences in the external and internal surfaces of the femoral bone. 170 
To determine the most optimal site for sampling, we first investigated the differences in prevalence 171 
and quantity of persisting viral DNAs in the external and internal surfaces of 27 femoral bones (Fig 172 
1). To this end, we examined three ubiquitous viruses (torque teno, parvovirus B19, and Epstein-173 
Barr virus) known to infect >70% of the global population and to persist in several soft tissues in the 174 
body. To control for bias by uneven amounts of DNA in the extracts, we performed in parallel a qPCR 175 
for the human single-copy gene RNAse P. We found no significant differences in the viral DNA 176 
prevalences (p>0.1) nor copy numbers (p values >0.5) between these two surfaces. Hence, 177 
subsequent analyses were performed only on samples taken from the external surface. 178 
 179 
Fig 1. Viral loads in the external and internal surfaces of the femoral bone. The numbers of cells as well 180 
as the DNA copies of torque teno virus (TTV), parvovirus B19 (B19V), and Epstein-Barr virus (EBV) from the 181 
external and internal surfaces of femoral bone were determined. No significant differences between these two 182 
locations were observed (p> 0.5). The cell counts are expressed per 1 µl of DNA extract and the viral DNA 183 
copy numbers per 1E6 cells. 184 
Viruses are highly prevalent in human femoral bone 185 
We then investigated the prevalences of altogether 38 persistent virus genomes using targeted 186 
enrichment and confirmatory qPCRs.  Overall, the 27 study subjects harbored on average 2.6 virus-187 
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types in their femoral bones, with a maximum of seven in one individual. Altogether, we detected 12 188 
different virus-types in 92.6 % of the bones, with only two individuals (> 60 years of age) being 189 
completely negative for all viruses tested. The viral findings are presented in Table 1 and Figure 2. 190 
The viruses most prevalent in bone were torque teno virus and parvovirus B19 with genoprevalences 191 
of 81.5% and 74.1%, respectively (Table 1). The third most prevalent was Merkel cell polyomavirus 192 
at 33.3%, followed by Epstein-Barr virus (25.9%), human papillomavirus (22.2%), human 193 
herpesvirus 7 (18.5%) and JC polyomavirus (14.8%). Other viral sequences detected were of herpes 194 
simplex 1, varicella-zoster, cytomegalovirus, human herpesvirus 6B, and hepatitis B virus. 195 
The median viral copy numbers per one million cells were 1.9E4 for torque teno virus, 2.4E3 for 196 
parvovirus B19, 8.7E3 for Merkel cell polyomavirus, and 2.1E1 for Epstein-Barr virus (Table 1). 197 
The most common co-occurrences were of parvovirus B19 and torque teno virus, found in 70.3% of 198 
the samples. Interestingly, we detected in the bone of one individual three cancer-associated viruses: 199 
hepatitis B virus, human papillomavirus type 31, and Merkel cell polyomavirus. 200 
Table 1. Viral DNA prevalence in human femoral bone 201 























HSV1 152 3.7 % 1 1 3.4 % 4.9E1 
VZV 125 3.7 % 1 1 13.6 % 2.0E0 
EBV 170 25.9 % 6 4 1.0-3.3 % 2.1E1 
CMV 236 3.7 % 0 1 - 9.8E1 
HHV6B 162 11.1 % 3 0 2.0-3.1 % - 
HHV7 150 18.5 % 5 0 4.8-12.0 % - 
JCPyV 5.1 14.8 % 3 2 3.7-14.8 % 2.7E1 
MCPyV 5.4 33.3 % 9 4 1.4-58.6 % 8.7E3 
Papillomaviridae HPV 8 22.2 % 6 1* 1.8-89.6 % 8.7E3 
Hepadnaviridae HBV 3.2 7.4 % 2 1 15.6-44.5 % 1.7E3 
Anelloviridae TTV 3.8 81.5 % 9 22 2.1-56.3 % 1.9E4 
* Only HPV type 31 qPCR was performed.  B19V: parvovirus B19; HSV1: herpes simplex virus-1; VZV: varicella-zoster virus; EBV: 202 
Epstein-Barr virus; CMV: cytomegalovirus; HHV6B: human herpesvirus 6B; HHV7: human herpesvirus 7; JCPyV: JC polyomavirus; 203 
MCPyV: Merkel cell polyomavirus; HPV: human papillomavirus; HBV: hepatitis B virus; TTV: torque teno virus 204 
We verified the accuracy of the qPCR results by examining the patterns of DNA fragmentation in the 205 
extracts and by evaluating the impact of potential inhibitors carried over during lysis and extraction. 206 
The quality of the total DNA in each sample was analyzed with a LabChip GX Instrument, which 207 
revealed 100 to 500 nt fragments in addition to intact genomic DNA (≤40 kb; Fig 3). We found no 208 







Fig 2. Viral DNA occurrence by NGS and qPCR in bone per study subject. The viral findings are 214 
presented as green (NGS+, qPCR+), yellow (NGS+, qPCR-), orange (NGS-, qPCR+), and white 215 
(NGS-, qPCR-). *The cause of death (COD) is given according to the WHO ICD10 classification. 216 
^The manner of death (MOD) is presented as 1=disease, 2=occupational disease, 3=injury, 217 
5=suicide. The results are presented from left to right according to the highest and lowest virus 218 
prevalences in bone. B19V= parvovirus B19; HSV1=herpes simplex virus-1; VZV= varicella-zoster 219 
virus; EBV= Epstein-Barr virus; CMV= cytomegalovirus; HHV6B= human herpesvirus 6B; HHV7= 220 
human herpesvirus 7; JCPyV= JC polyomavirus; MCPyV= Merkel cell polyomavirus; HPV= human 221 
papillomavirus; HBV= hepatitis B virus; TTV= torque teno virus. 222 
 223 
Fig 3. DNA fragment analysis of total DNA. Fragment length distribution of patterns of genomic 224 
DNA for four representative samples as established with LabChip GX. 225 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
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Viral capture and sequence analysis 226 
As established from the qPCR results, the persisting viral DNA quantities were far below 1% of total 227 
DNA present in a sample. Thus, to enrich this fraction, we performed in-solution capture with 228 
biotinylated RNA oligonucleotides prior to sequencing in Novaseq 6000. Subsequently, we analyzed 229 
the NGS data with a custom pipeline, TRACESPipe (Pratas et al. in revision), which reconstructs the 230 
viral sequences using both reference-based alignment and de-novo assembly. 231 
We reconstructed a total of 15 viral genomic sequences, with a minimum of 15% breadth coverage. 232 
The highest qualities were attained for parvovirus B19 (n=7; average breadth coverage 86.1%), 233 
human papillomavirus (n=1; breadth coverage 89.6%), Merkel cell polyomavirus (n=1; breath 234 
coverage 58.6%), JC polyomavirus (n=1; breadth coverage 14.8%), hepatitis B virus (n=2; breadth 235 
coverages 44.5% and 15.6%), and torque teno virus (n=3; breadth coverages 56.3%, 30.6% and 236 




Fig 4. Coverage profiles of reconstructed viral DNA sequences. NGS coverage profiles (breadth and 239 
depth) of representative viruses. 240 
12 
 
By NCBI BLAST, we found close relation of the reconstructed genomes to previously published 241 
sequences. We recovered seven full/near-full B19V genomic sequences, three of which were of 242 
genotype 1 (95.16% to 99.61% similarity to AY504945.1) and four of genotype 2 (90.1% to 98.6%, 243 
similarity to AB550331.1). The latter genotype represents an extinct form of this virus and was found 244 
in the present study exclusively in individuals older than 68 years. Of this genotype, only a single 245 
full-length sequence has ever been published (AB550331.1). We found that this genotype’s hairpins 246 
present similar flip and flop configurations to those of genotype 1. 247 
The human papillomavirus sequence showed 99.1% similarity to type 31 (KU298889.1); Merkel cell 248 
polyomavirus 98.7% to the European/Caucasian type (KF266963.1) and JC polyomavirus 100.0% 249 
to genotype 1 (MF662198.1). The two hepatitis B virus sequences matched 99.4% and 99.6% to 250 
genotypes D (JX898691.1) and A (MN507849.1), respectively; and the torque teno virus sequences 251 
showed 90.2%, 99.0% and 96.2% similarity to strains AF122920.1, KT163880.1 and FR751497.1, 252 
respectively. 253 
Moreover, we confirmed by BLAST unique sequences (mean length 100 nt) mapping to the following 254 
viruses: herpes simplex 1 (1 case, 28 reads), varicella-zoster (1 case, 362 reads), Epstein Barr (6 255 
cases, altogether 270 reads), human herpesvirus 6B (3 cases, total of  66 reads), human herpesvirus 256 
7 (5 cases, total of 274 reads), JC polyomavirus (3 additional cases, total of 13 reads), Merkel cell 257 
polyomavirus (8 additional cases, total of 15 reads), human papillomavirus (5 additional cases, total 258 
of 14 reads), torque teno virus (6 additional cases, total of 26 reads), and parvovirus B19 (10 259 
additional cases, total of 673 reads). 260 
Discussion 261 
The analysis of viral DNAs shows great potential as complementary markers for human identification 262 
as well as for estimation of provenance and migration. However, one limitation of their use in these 263 
contexts is insufficient knowledge of the landscape of viruses persisting in the host, in particular in 264 
human bone, with only parvovirus B19[23,24] and hepatitis B[25] virus having been detected in this 265 
tissue so far. 266 
To this end, we systematically explored the prevalences of 38 ubiquitous viruses in human femoral 267 
bone. We discovered an unprecedented number of viral DNAs, detecting up to seven per individual. 268 
Besides the already known, we report here on ten new viruses including several members of the 269 
herpesvirus family (herpes simplex-1, varicella-zoster, Epstein-Barr, cytomegalovirus, human 270 
herpesviruses 6B and 7), JC- and Merkel cell polyomaviruses, human papillomavirus 31, and torque 271 
teno virus. Intriguingly, a common feature shared by these viruses (except for HHV-6B) is their 272 
persistence in soft tissues in episomal form[34]. Although the methods used in this study prevent us 273 
from confirming whether this is also the case in bone, the low copy numbers detected are indicative 274 
of a quiescent infection. Moreover, some of them (e.g. herpes-, polyoma-, and papillomaviruses) are 275 
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known to establish latency as densely packed nucleosomes, as mechanism to regulate gene 276 
expression[35,36]. Thus, the circular form and the tight histone packaging may confer DNA viruses 277 
superior preservation in relation to the host DNA (nuclear and mitochondrial)[37–39]. In this regard, 278 
the analysis of viral DNA could be of utmost value for forensic investigations or studies of ancient 279 
human remains dealing with highly compromised samples. 280 
One challenging factor in the study of the human virome continues to be its extremely low proportion 281 
in relation to other sources of DNA. With this in mind, we carried out our screening using two 282 
approaches, qPCR and NGS. We found that the viral DNAs were exceeded on average a 1000-fold 283 
by the nuclear DNA alone, in line with the loads reported for persisting viruses in soft tissues[40–42]. 284 
By targeted enrichment and NGS we identified a higher number of viruses than by qPCR, an 285 
observation that can in part be explained by moderate DNA fragmentation in the samples. The only 286 
exception was torque teno virus (TTV), for which we found a significantly higher number of positive 287 
samples by qPCR. This circular ssDNA virus exhibits substantial heterogeneity[43], which was 288 
under-represented by the three reference sequences upon which our baits were designed. Hence, 289 
a better characterization of it could require a broader bait coverage of its five genogroups together 290 
with analysis at the amino acid level, as certain motifs are more likely to be shared by different TTVs. 291 
The qPCR on the other hand, targeted the conserved UTR region, to recognize a wide a repertoire 292 
of TT-viruses. 293 
Unsurprisingly, larger genome coverages were recovered from the viruses with the highest copy 294 
numbers (~log3 copies/million cells). However, many of the viral loads fell below this threshold, 295 
whereby, follow-up singleplex enrichments may be beneficial to increase the analytical resolution of 296 
the data. Importantly, even for the low coverage genomes, we confirmed the sequences retrieved to 297 
be virus-specific and hence, genuine findings of the femoral bone. 298 
In all, we unveil that the human femoral bone is a much richer source of persistent DNA viruses than 299 
earlier known. We propose that a “Human Virome Panel” could be built as an efficient tool for 300 
assessment of human provenance in conjunction with the standard human DNA profiling. Indeed, 301 
the phylogeographical distributions of JC[13,14,44], BK[2], varicella-zoster[7], and Epstein Barr[6] 302 
viruses have been examined in this context and shown to add power to forensic cases and 303 
anthropological studies. Undoubtedly, larger cohorts, both global and local, are required to validate 304 
the benefits and boundaries of such panel in multiple taphonomic conditions. This work could also 305 
help to identify patterns in the age distributions of certain viruses and their genotypes[19,20], to 306 
support biometric estimations. 307 
Moreover, our data raise intriguing questions on the clinical significance of the long-term presence 308 
of these viruses – or their genomes – in the human skeleton. Indeed, many of the viruses we found 309 
can reactivate, and several have oncogenic potential. Among the latter, we detected Merkel cell 310 
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polyomavirus and human papillomavirus 31, two oncoviruses which, remarkably, are 311 
mucocutaneous. Certainly, these unexpected findings warrant further studies on the transcriptional, 312 
translational and reactivation potential of these pathogens as bone residents, particularly among the 313 
elderly and immune suppressed. 314 
Conclusions 315 
Our work substantially expands the current knowledge on the spectrum of DNA viruses persisting in 316 
human bone and opens new perspectives on their applicability in the investigation of human skeletal 317 
remains. It also supports the search for viruses from ancient relics, which can foreseeably remodel 318 
our understanding of virus evolution. 319 
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